Wells Pharmacy, Inc.
FDA 503B outsourcing facility
Dyersburg, Tennessee
Key Takeaways
- FDA-registered 503B outsourcing facility since 2016
- Sterile compounding from bulk substances: Yes
- Last FDA inspection: April 9, 2026
About this facility
A 503B outsourcing facility is registered with the FDA under the Drug Quality and Security Act and may compound sterile medications in bulk without patient-specific prescriptions, under cGMP manufacturing standards. How federal compounding status works.
FDA registration and inspection record
- First registered with FDA
- June 7, 2016
- Most recent registration
- November 28, 2025
- Compounds sterile drugs from bulk substances
- Yes
- Last FDA inspection
- April 9, 2026
- NPI
- 1790034460
The FDA last inspected Wells Pharmacy, Inc. on April 9, 2026. Investigators issued a Form FDA 483 listing inspectional observations at that visit. The FDA has not yet determined whether further action will be taken.
What this facility compounds
Wells Pharmacy, Inc. reports compounding 5 distinct active ingredients to the FDA Outsourcing Facility Product Report (most recent reporting periods).
- Estradiol
- Progesterone
- Testosterone
- Testosterone; Anastrozole
- Tetracaine; Benzocaine; Lidocaine
Location
450 US HIGHWAY 51 BYP N, Dyersburg, TN
Contact
FDA-registered contact: Melissa Stefko, 800-622-4510. Source: the facility's FDA outsourcing registration.
License verification
503B outsourcing facilities are also licensed by the state board of pharmacy. Verify the current license status of Wells Pharmacy, Inc. with the Tennessee Board of Pharmacy.
503B facilities in Tennessee
Tennessee has 2 FDA-registered 503B outsourcing facilities in the PeptideGrids directory. See all 503B facilities in Tennessee.
Frequently asked questions
Is Wells Pharmacy, Inc. registered with the FDA?
Yes. Wells Pharmacy, Inc. is a registered 503B outsourcing facility, first registered with the FDA on June 7, 2016 and most recently registered on November 28, 2025.
Has Wells Pharmacy, Inc. been inspected by the FDA?
The FDA last inspected Wells Pharmacy, Inc. on April 9, 2026. A Form FDA 483 was issued.
Has Wells Pharmacy, Inc. had any FDA drug recalls?
No FDA drug recalls are matched to Wells Pharmacy, Inc. in the openFDA enforcement database.
What does Wells Pharmacy, Inc. compound?
Wells Pharmacy, Inc. reports compounding 5 active ingredients to the FDA.
Where is Wells Pharmacy, Inc. located?
Wells Pharmacy, Inc. is located in Dyersburg, Tennessee (450 US HIGHWAY 51 BYP N).
Registration and inspection data verified against the FDA list of registered outsourcing facilities on June 6, 2026.
PeptideGrids is independent and not affiliated with, endorsed by, or sponsored by Wells Pharmacy, Inc.. Listings, registration, inspection, and recall data are reported from public FDA records for informational purposes only. A recall or inspection finding is not an accusation of current wrongdoing. This is not medical or legal advice. To request a correction, see our corrections policy.